Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using remote monitoring with community health workers to help Latinx patients manage hypertension

Official title: Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients

Run by NYU Langone Health · NCT06730230 · Data updated 2026-11-12

This study tests whether using remote monitoring with the help of community health workers can better help Latinx patients manage their high blood pressure compared to regular care.

More Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorNYU Langone Health
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedFebruary 10, 2025
Main results expectedMay 31, 2026
Study endsMay 31, 2027
Registry record updatedDecember 4, 2025
Trial IDNCT06730230 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Latinx individuals aged 18 and older with uncontrolled hypertension and non-adherence to prescribed antihypertensive medications.

Probably not a fit

Patients who are unable to comply with the study protocol or have significant psychiatric comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a remote patient monitoring (RPM) program supported by community health workers (CHWs) in managing hypertension among Latinx patients. It employs a step-wedge randomized controlled trial design to compare the RPM-enabled CHW approach with standard care for hypertension management. The study will assess various outcomes including blood pressure reduction, implementation effectiveness, and factors such as adoption, acceptability, and sustainability of the RPM program.

Why it matters

Potential benefit: If successful, this approach could significantly improve blood pressure management and health outcomes for Latinx patients with hypertension.

How similar studies have gone: Other studies have shown promise in using community health workers and technology for chronic disease management, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Self-identify as Latinx
2. Be fluent in English or Spanish
3. Be age 18 years or older
4. Receiving care at one of the 10 safety-net primary care clinics
5. Have uncontrolled HTN documented in the electronic health record (EHR) on at least two visits in the past year (defined as an average BP ≥ 140/90 mmHg)
6. Have been prescribed at least one anti-hypertensive medication and be non-adherent to their medications, defined as adherence \<80% in the preceding 12 months, as determined by prescription orders obtained from the clinic EHR.

Exclusion Criteria:

1. Being deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks)
2. Participation in other hypertension-related clinical trials
3. Have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR)
4. Plan to discontinue care at the clinic within the next 15 months

Where it's running

  • NYU Langone Health
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.